Effectively managing strategic and tactical outsourcing partners to maximise the efficiency of global trials and speed time to market for new drugs
Outsourcing has become vastly popular among biotech and pharma companies with an estimated third of all R&D budgets now being spent on CROs. As rewarding as this practice can be however, there are still multiple challenges to be faced such as choosing an appropriate outsourcing strategy, selecting a CRO, project managing the trial and ensuring that the company achieves the desired outcome in the desired timeline.
Case studies from industry key players, as well as interactive sessions will offer attendees a unique opportunity to interact and exchange ideas with fellow experts facing similar challenges, assess the industry trends, maximise alliance opportunities and take advantage of the practical experience of the most knowledgeable experts in the business.
Outsourcing has become vastly popular among biotech and pharma companies with an estimated third of all R&D budgets now being spent on CROs. As rewarding as this practice can be however, there are still multiple challenges to be faced such as choosing an appropriate outsourcing strategy, selecting a CRO, project managing the trial and ensuring that the company achieves the desired outcome in the desired timeline.
Case studies from industry key players, as well as interactive sessions will offer attendees a unique opportunity to interact and exchange ideas with fellow experts facing similar challenges, assess the industry trends, maximise alliance opportunities and take advantage of the practical experience of the most knowledgeable experts in the business.
